Any student who has severe allergies and carries an Auvi-Q injector for treatment of anaphylactic allergic reaction (note: this does NOT apply to Epi-Pen injectors, which are a different company’s product) should be sure to check out the recall information to make sure their Auvi-Q injector is safe.
Sanofi US is voluntarily recalling ALL Auvi‑Q® (epinephrine injection, USP). The recall involves all Auvi‑Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot number 2299596 through 3037230, which expire March 2016 through December 2016. The products have been found to potentially have inaccurate dosage delivery. (Detailed FAQ in this link)